Financial Comparison: USANA Health Sciences (USNA) vs. Its Competitors

USANA Health Sciences (NYSE:USNA) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it weigh in compared to its rivals? We will compare USANA Health Sciences to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, valuation, risk, dividends and earnings.

Risk and Volatility

USANA Health Sciences has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Comparatively, USANA Health Sciences’ rivals have a beta of 0.81, indicating that their average share price is 19% less volatile than the S&P 500.

Insider & Institutional Ownership

54.2% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 48.6% of shares of all “Personal Care Products” companies are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Comparatively, 11.9% of shares of all “Personal Care Products” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings and recommmendations for USANA Health Sciences and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1	1	0	0	1.50
USANA Health Sciences Competitors	895	2916	3642	226	2.42

As a group, “Personal Care Products” companies have a potential upside of 2.40%. Given USANA Health Sciences’ rivals stronger consensus rating and higher probable upside, analysts clearly believe USANA Health Sciences has less favorable growth aspects than its rivals.

Profitability

This table compares USANA Health Sciences and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
USANA Health Sciences Competitors	-5.59%	-65.81%	-0.33%

Earnings and Valuation

This table compares USANA Health Sciences and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
USANA Health Sciences	$925.26 million	$10.76 million	-11.79
USANA Health Sciences Competitors	$7.77 billion	$1.11 billion	11.62

USANA Health Sciences’ rivals have higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

USANA Health Sciences rivals beat USANA Health Sciences on 9 of the 13 factors compared.

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.